PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections

Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Alison, Cass, Lindsey, Ito, Kazuhiro, Pagani, Nicole, Armstrong-James, Darius, Dalal, Paras, Reed, Anna, Strong, Pete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765807/
https://www.ncbi.nlm.nih.gov/pubmed/33348852
http://dx.doi.org/10.3390/jof6040373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765807/
https://www.ncbi.nlm.nih.gov/pubmed/33348852
http://dx.doi.org/10.3390/jof6040373

Ejemplares similares